
© 2024 ARIVA.de
Realtime | Geld | Brief | Zeit |
---|---|---|---|
108,50 | 108,75 | 07:03 | |
108,80 | 109,50 | 07.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks | ||
Fr | Biogen downgraded to Hold at Argus on profit decline expectations | ||
Do | BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag | ||
Do | RBC Capital cuts Biogen stock price target to $221 | ||
Do | FDA grants fast track status to Biogen's BIIB080 for Alzheimer's |